This article reviews literature up to mid-1988 covering recent developments pertaining to agonist-induced Ca2`signaling in various cell types. A large amount of experimental evidence supports a mechanism involving specific guanine nucleotide-binding proteins (G-proteins) as transducing factors between occupancy of a wide variety of receptors by many different agonists and activation of polyphosphoinositide specific phospholipase C enzymes. Although many different G-proteins and phospholipase C enzymes have been purified and cloned, successful reconstitution of the components has not been achieved. Hence, many questions concerning the specificity of coupling between particular receptors to a particular G-protein and phospholipase C subtype remain unresolved. Phospholipase C subtypes isolated from the membrane and soluble fractions of the cell are directly activated by Ca2" and, preferentially, hydrolyse phosphatidylinositol 4,5-bisphosphate (PIP2) and phosphatidylinositol 4-phosphate (PIP). The role of the G-protein is to stimulate inositol lipid breakdown at free Ca2' concentrations (0.1-0.2 FM) typical of unstimulated cells. Overwhelming evidence supports the concept that Ins 1,4,5-P3, the product of PIP2 hydrolysis, is responsible for the initial agonist-induced Ca2' transient by mobilization of Ca2+ from a specialized intracellular store. An Ins 1,4,5-P3 receptor has been purified that may correspond to the postulated Ins 1,4,5-P8 gated Ca21 channel. Despite a growing understanding of the complexities of the metabolism of Ins 1,4,5-P8 and a successful purification of many enzymes involved, including the ATP-dependent 3-kinase that converts Ins 1,4,5-P8 to Ins 1,3,4,5-P4, the role of Ins 1,3,4,5-P4 as a putative second messenger remains enigmatic. Multiple forms of protein kinase C have been described and the role is well established for a 1,2-diacylglycerol, the second product of PIP2 hydrolysis, as its physiological activator. Although protein kinase C has been shown to phosphorylate and modulate the activity of several proteins involved in the Ca2' signaling pathway and Ca2+ transport, the physiological significance of the protein kinase C in agoniststimulated cell function requires further elucidation. The extension of measurements of hormoneinduced Ca2+ changes to single cells has shown that the occurrence of Ca2+ oscillations is a common phenomena. Elucidation of the biochemical mechanisms causing this oscillatory response and its physiological significance represents an important challenge for future studies.
Introduction
The cytosolic free Ca2" concentration functions as an important intracellular signaling mechanism whereby hormones and growth factors regulate many different cellular processes such as secretion, metabolism, neurotransmitter release, cell growth, and differentiation. Signal transduction by the ligandactivated receptor is mediated by specific guanine nucleotide binding proteins (G-proteins), which activate phospholipase C-mediated hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) in the plasma membrane. The products of this reaction are 1,2-diacylglycerol, which is retained in the plasma membrane, and D-myo-inositol-1,4,5-trisphosphate gene products involved in cell growth (5, 6 ). These latter effects may be mediated by protein kinase C isozymes that are different from those responsible for the short-term effects (7) (8) (9) .
Despite a general acceptance of the overall sequence of events responsible for linking receptor activation to increases of cytosolic free Ca2" (10) (11) (12) (13) , many details of the mechanisms underlying each step remain unresolved. Recent advances suggest a high level of cellular diversification and the presence of an intricate network of positive and negative controls providing continuous regulation of the response elicited by receptor activation.
This review will describe recent findings concerning various types of novel G-proteins and phospholipases found in different cells, and the mechanisms involved in regulation of Ca2' flux across the plasma and intracellular membranes. These mechanisms, together with a variety of feedback controls, could account for diverse cellular Ca2+ responses seen in different tissues, as well as the marked heterogeneity of response seen in single cells within a population, including an oscillatory behavior of the Ca2' signal.
Generation of Intracellular Second Messengers
The feature that appears to be common to different cell types for agonist-induced Ca21 mobilization involves an interaction in the plasma membrane between three different types of proteins, namely, receptors, G-proteins, and phospholipase C. Most cells contain many different types of receptors in the plasma membrane which, upon stimulation by suitable agonists, cause an increase of cytosolic free Ca2' (10, (14) (15) (16) . The number of receptors and their affinity determines the relative sensitivity of the cell to each agonist and the extent of phospholipase C activation. Since a particular agonist is often capable of interacting with several different subtypes of receptors, the specificity of signal transduction is likely to be determined by the nature and properties of the G-protein that interacts with a particular receptor subtype and effector system (17) .
The Role of G-Proteins in Activating Phospholipases
The structure and molecular properties of G-proteins and their role in signal transduction have been reviewed recently (18, 19) . Those involved in receptor coupling in the plasma membrane act as both on/off switches and a mechanism for signal channelling and amplification. Generally they are present in greater abundance than the receptor proteins. G-proteins typically have a heterotrimeric apy structure. The asubunit is the site for GTP-binding, and differences in their primary structure (20) (21) (22) (23) provides the basis for their specific roles as transducing agents. A general model for G-protein action has been proposed, which is based on numerous studies concerned with the mechanism of activation of adenylate cyclase and photoreceptor function (18, 24) . Binding of agonist to the receptor causes the exchange of guanosine diphosphate (GDP) for guanosine triphosphate (GTP) on the G-protein a-subunit. This is accompanied by a dissociation of the a-subunit from the heterotrimer and a decreased binding affinity of the agonist to the receptor. The activated (GTP-bound) a-subunit then interacts with and modifies the activity of the effector protein. The G-protein a-subunits have an intrinsic GTPase activity, yielding inactive a-GDP complexes, which reassociate with the available pool of Py-dimers to reform the heterotrimeric G-protein, which can then undergo further cycles of activationdeactivation with signal amplification. Different forms of P-and -y-subunits also exist, but the primary role of the more lipophilic Py complexes, or myristoylated a-subunits, (25) might be to anchor the G-protein in the membrane, possibly adjacent to a particular receptor subtype.
Several properties of the G-proteins provide useful tools for investigating their functional role in cellular processes. Nonhydrolyzable GTP analogues such as GTPyS cause a persistent activation of G-proteins, but GDP,S, which mimics GDP, is inhibitory. Another property of the G-protein a-subunits is their susceptibility to ADP-ribosylation by bacterial toxins. Cholera toxin catalyses ADP-ribosylation at an arginine site of several G-proteins, and pertussis toxin causes ADP-ribosylation at a cysteine site, located near the carboxyl terminus, and uncouples the G-protein from the receptor. The a-subunits of different G-proteins may be ADP-ribosylated by cholera or pertussis toxins (18) . Notably, the G-protein responsible for stimulating adenylate cyclase (Gs) is a substrate for cholera toxin, while the G-protein associated with inhibition of adenylate cyclase (Gi), and a G-protein prevalent in brain (Go) are substrates for pertussis toxin.
The original evidence leading to the conclusion that G-proteins are involved in receptor coupling of Ca2+-mobilizing agonists to PIP2 breakdown was reviewed recently (12, 19, 26, 27) . The basic observations are that G-protein activating agents such as GTP, GTPyS or AlF3 (which mimics GTP binding) when added to permeabilized cells or plasma membrane preparations cause an activation of phospholipase C and a decrease of agonist binding affinity. Further evidence is provided by a) the enhancement of phospholipase C activation by suboptimal concentrations of GTPyS in the presence of agonist, b) an agonist-induced stimulation of GTPase activity, c) the inhibition of phospholipase C activation by GDP,S, d) an inhibition of agonist-induced activation of phospholipase C by toxins (some cell types only), and e) the retention of receptor-G-protein complexes (28) (29) (30) or G-proteinphospholipase C complexes (31) during purification. Current evidence suggests that a variety of different types of G-proteins are responsible for regulating receptor coupling to phospholipase C in different cell types. This was first suggested by the fact that agonist-mediated stimulation of inositol phosphate formation and Ca2' mobilization could be inhibited by pertussis toxin pretreatment in some cell types, but not others [for references and details of cell types see (26) ]. Ca2' mobilization induced by activation of different receptors can also be selectively inhibited by pertussis toxin pretreatment in the same cell type. In hepatocytes, epidermal growth factor (EGF) responses are pertussis-toxin sensitive, whereas those to vasopressin or angiotensin II are not (32) . In platelets, pertussis toxin inhibits thrombin but not U46619 (a thromboxane A2 analogue) responses (33) . Further, heterogeneity in the type of G-protein able to couple to phospholipase C is suggested by the ability of cholera toxin to inhibit the effects of Ca2'-mobilizing agonists in a variety of cell types (27, (34) (35) (36) (37) . This effect of cholera toxin was independent of ADP-ribosylation of G. and changes of cyclic AMP.
A number of novel G-proteins that may be involved in coupling to phospholipase C have been identified in various cells. In neutrophils and human leukemia HL-60 cells (30, (38) (39) (40) , a pertussis toxin-sensitive 40 kDa a-subunit has been purified and shown to be immunologically distinct from the a-subunits of Go and Gi. The copurification of this 40 kDa polypeptide with the chemoattractant receptor suggests that it is responsible for activation of phospholipase C (30) . This same 40 kDa a-subunit from HL60 cells is ADP-ribosylated by cholera toxin in the presence of the Ca2'-mobilizing chemotatic peptide fMet-Leu-Phe, as well as by pertussis toxin (34, 35) .
A pertussis toxin-sensitive 40 kDa a-subunit has been isolated from brain (41) and shown to be structurally and immunologically similar to Gia40 from neutrophils and HL-60 cells (21, 22) . Reconstitution studies performed by adding Gi or Go prepared from brain to plasma membranes from HL-60 cells previously treated with pertussis toxin showed that they were equally effective in restoring fMet-Leu-Phe plus GTP-stimulated formation of inositol phosphates (42). Addition of Go or Gi also restored bradykinindependent activation of GTPase and inhibition of adenylate cyclase in membranes from NG108-15 cells treated with pertussis toxin (43). Furthermore, Go or Gi stimulated the activity of partially purified phospholipase C from platelet membranes (44). These results suggest an apparent promiscuity of G-protein coupling to phospholipase C, but since the preparations of Go or Gi used in these experiments probably contained Ga40, it seems more likely that this G-protein, which also stimulates phospholipase C activity (44), provides specificity for G-protein-phospholipase C coupling.
A different pertussis toxin target protein with an apparent molecular mass of 43 kDa has been partially purified from human erythrocytes (45). This protein has the properties expected for a G-protein a-subunit and is also present in membranes from brain, GH4C1 pituitary cells, leukocytes, and liver (45). A 54 kDa protein that was ADP-ribosylated by pertussis toxin and that copurified with an inositol lipid specific phospholipase C has been identified in the cytosolic fraction of thymocytes (31) , while a pertussis toxin insensitive GTP-binding protein was found associated with purified vasopressin receptors in rat liver (28, 29) . Some indirect evidence suggests the possibility that an unidentified pertussis toxin sensitive Gprotein may be involved in inhibiting phospholipase C (32, 46, 47) . Several members of a group of G-proteins with Mr values betwen 20,000 and 25,000, including the well-characterized p21 ras oncogene product (48), have been purified but their possible function in relation to inositol lipid metabolism has not been elucidated (see 49).
In summary, growing evidence suggests that several different G-proteins are responsible for activating phospholipase C. A number of novel G-protein asubunits have been identified by protein purification, and multiple forms of Gi-and Go-like a-subunits with high-sequence homology have been identified by cDNA cloning (20, 21) and by reaction with different antibodies (22, 50, 51) . These studies also indicate that the Gia41 that couples with receptors to inhibit adenylate cyclase activity is unlikely to activate phospholipase C. A new G-protein a-subunit has been identified from molecular cloning of cDNA, which is Gi-like but has a lower sequence homology than other known G-protein a-subunits. This subunit is particularly interesting because it lacks the cysteine site at the carboxyl terminus for ADP-ribosylation by pertussis toxin (52,53). If this G-protein is found to be widely expressed, it may account for pertussis toxin insensitivity of receptor coupling to phospholipase C observed in many tissues.
Phospholipases as G-Protein Effector Enzymes
Several inositol lipid-specific phospholipase C enzymes have been found in both the soluble and plasma membrane fractions of the cell (53). Membrane-bound phospholipase C has been purified after detergent solubilization from brain, with a molecular mass of 150 to 154 kDa (55,56); 61 kDa and 62 kDa enzymes have been purified from platelets (57) and uterus (58) , respectively. Molecular cloning and determination of the complete amino acid sequence has been achieved for a number of phosphatidylinositolspecific phospholipase C enzymes from brain (59) (60) (61) (62) and uterus (63) , which show a remarkable lack of sequence homology. Generally, these enzymes will hydrolyse phosphatidylinositol (PI), phosphatidylinositol 4-phosphate (PIP), and PIP2 at high Ca2" concentrations, but they are more active toward PIP and PIP2 at CA2+ concentrations below 10 gM. Forms of phospholipase C, apparently specific for PI and not for polyphosphoinositides, have also been recognized (64, 65) . As shown in intact membrane preparations from a number of cell types, the major effect of activated G-protein on PIP2-specific phospholipase C activity is to decrease the Ca21 concentration required for enzyme activity to the physiological level of about 0.1 iM (66) (67) (68) (69) . In platelets, where most of the phospholipase C activity is recoverable from the soluble cell fraction, the partially purified enzyme is stimulated by GTPyS (70) (71) (72) . In contrast, soluble phospholipase C from liver is not stimulated by GTPyS (69) . At present, it remains an open question whether or not G-protein a-subunits in some tissues may dissociate from the membrane after receptor activation and, subsequently, interact with intracellular effector enzymes (73) .
Some tissues also contain a phospholipase C specific for phosphatidylcholine, which appears to be coupled to receptors by an unidentified G-protein (74, 75) . Other types of phospholipase C specific for a PI-glycan structure involved in membrane-anchored proteins and insulin action have been described [see (76) 
Regulation of Ins 1,4,5-P3 Production
In the intact cell Ins 1,4,5-P3 is formed together with small amounts of the 1,2 cyclic isomer only by phospholipase C-mediated hydrolysis of PIP2 (see 84 for review). The amount of PIP2 that is available for hydrolysis is only sufficient to maintain Ins 1,4,5-P3 production for a few minutes. However, this hormone-sensitive PIP2 pool is rapidly replenished via PIP from part of the much large PI pool by the action of PI and PIP kinases (11, 12) . These enzymes exist in multiple forms, and there is evidence that some types are activated by tyrosine kinases (85) or by protein kinase C (86) . The large PI pool and the high activity of the enzymes synthesizing PIP2 mitigates against the regulation of Ins 1,4,5-P3 production by a limitation of substrate availability.
The production of Ins 1,4,5-P3 is subject to several kinds of feedback regulation. A rapid inhibition of agonist-induced Ins 1,4,5-P3 production and Ca2" signaling is observed in many cell types by phorbol ester-induced activation of protein kinase C (3, 10, 12, 79) . This interaction can either be at the receptor or a post-receptor site. Some receptors, notably a1-adrenergic and EGF receptors, are phosphorylated by protein kinase C with decreased agonist binding and prevention of agonist-mediated signal transduction to the G-proteins. (87) . Phosphorylation of the a1-adrenergic receptor by agonists has been demonstrated in DDT1 MF-2 smooth muscle cells (88) . The purified a1-adrenergic receptor is also phosphorylated by protein kinase C (89) . Receptor phosphorylation, however, does not seem to be a general mechanism for phorbol ester (PMA)-induced inhibition of agonist effects. Thus, an additional post-receptor site for protein kinase C-mediated interaction is suggested from studies with plasma membrane preparations. These showed no effect of PMA pretreatment on agonist binding affinity nor the ability of GTP analogues to suppress high-affinity agonist binding (90), but they did show an inhibitory effect on GTPyS-stimulated hydrolysis of PIP2 (90, 91) . Since the production of Ins 1,4,5-P3 as well as Ca21 mobilization is inhibited by the activation of protein kinase C, the site for the post-receptor interaction is thought to be at the G-protein-phospholipase C complex. Although several G-protein a-subunits (notably Gia41) have been shown to be phosphorylated by protein kinase C (92, 93) , clear evidence for the phosphorylation of an a-subunit functionally coupled to phospholipase C is presently lacking. Purified pholpholipase C from uterine smooth muscle can be phosphorylated by protein kinase C, but the ability to hydrolyze PIP2 was unaffected (58) . Resolution of the different mechanisms responsible for regulating Ins 1,4,5-P3 production by activating protein kinase C will undoubtedly be aided by isolating and reconstituting functional receptor-G-protein phospholipase C complexes and using selective protein kinase C inhibitors in intact cells. (95, 98, 99) . This enzyme appears to be activated by protein kinase C (100), while the 5-phosphomonoesterase has also been shown to be phosphorylated and activated by protein kinase C (101). However, there is some doubt whether or not the latter effect occurs in the intact cell, since the inhibition of protein kinase-C in platelets by staurosporine had no effect on thrombin-induced increases of inositol phosphates (102) . 
Intracellular Ca2+ Mobilization
The Hormone-Sensitive Ca2`Pool Recent evaluations of the tissue distribution of total Ca2+ between the cytosol and the different organelles have led to the conclusion that the bulk of the sequestered Ca2+ is in the endoplasmic reticulum (105, 106) . It is also generally accepted that this pool represents the source of the Ca2+ released by Ca2+-mobilizing agonists. However, the endoplasmic reticular structures are themselves heterogeneous, as are the pools of sequestered Ca2". This is revealed by the fact that, in numerous studies after adding agonists to intact cells or Ins 1,4,5-P3 to permeabilized cells and isolated microsomal preparations, only a fraction of the sequestered Ca2" is released (10) . Recent studies have, in fact, suggested that a morphologically discrete organelle termed the calciosome, which generally copurifies with endoplasmic reticulum membranes, may represent the source of hormone releasable Ca2" in nonmuscle cells (107) . In some cells, such as smooth muscle (108) (114) and other tissues (106) . This enzyme belongs to the class of E1P.E2P-ATPases and is biochemically, kinetically, and immunologically similar to the enzyme in skeletal muscle sarcoplasmic reticulum (115) . In some cell types it is also calmodulindependent (106) . As with sarcoplasmic reticulum, the Ca21 sequestered by the endoplasmic reticulum is in equilibrium between free and bound forms. It (118) . Evidence obtained with saponized platelets suggests that the activation of protein kinase C may account for a similar stimulation of Ca2" sequestration after thrombin addition (119) (137, (151) (152) (153) (154) . GTP has been reported to promote fusion between microsomal vesicles, which correlated with the rate of GTP-mediated Ca2" release (151) . On the other hand, Nicchitta et al. (153) showed that GTP induced a nonspecific permeability of the liver microsomal membrane. The GTP effect on Ca21 release in liver microsomes is associated with a polyethylene glycol-promoted increase of GTPase activity (155) , suggesting the involvement of a GTP-binding protein. In contrast to the effects of GTP-yS on Gproteins involved in receptor signaling, GTP-yS inhibits the GTPase activity and GTP-mediated Ca2" release (155) .
Experiments with permeabilized neuronal and smooth muscle cell lines showed that Ins 1,4,5-P3 released Ca2" from the same pool as GTP, while GTP also released Ca2" from an additional nonmitochondrial pool (156) . In further studies, Gill and his colleagues suggested that uptake of Ca21 into the Ins 1,4,5-P3-sensitive Ca2' pool is controlled by a GTPregulated Ca21-translocating mechanism (157) . In permeabilized hepatocytes, under certain conditions GTP enhanced the Ins 1,4,5-P3-induced Ca2" release (158) . At present, the physiological significance of the GTP effect is not clear. Although it is unlikely that GTP activates a specific Ca2" channel, it is possible that through the mediation of an intracellular GTPbinding protein, the GTP may unmask Ins 1,4,5-P3-binding sites, increase the size of the Ins 1,4,5-P3-sensitive Ca2' pool, or be involved in the translocation of the calciosomes closer to the plasma membrane where Ins 1,4,5-P3 is generated.
In a number of studies using membrane fractions derived from liver, adrenal cortex, macrophages, neutrophils, anterior pituitary, and brain (159,160) the density and affinity of Ins 1,4,5-P3 binding sites have been characterized. Several reports indicate that plasma membrane-enriched fractions of liver (159) and platelets (161) (162) , and is about 100 times greater than that observed in peripheral tissues. The half-maximum binding (40-80 nM) in cerebellar membranes (160) is also higher than values of 1 to 10 nM reported in other tissues (159) . Thus, there is an apparent, large discrepancy between these low values for half maximum Ins 1,4,5-P3 binding and the half maximum concentration of Ins 1,4,5-P3 (0.1 to 2 FM) required to release Ca2+ from permeabilized cells or isolated microsomes (10) . Several factors are known to affect the Ins 1,4,5-P3 binding affinity that may account for this apparent discrepancy. Notably, Ins 1,4,5-P3 binding is lower at physiological pH than at the more alkaline pH values typically used for binding studies (160) and is also inhibited by ATP (159) . Furthermore, the transient nature of the Ca2' release elicited by Ins 1,4,5-P3 in permeabilized cells and membrane preparations reflects its further metabolism to relatively inactive products, so that the Ins 1,4,5-P3 concentrations present in the medium might be overestimated.
The Ins 1,4,5-P3 receptor has recently been purified from rat cerebellum using a heparin affinity column (163) . This solubilized membrane protein was shown to have a molecular mass of 260 kDa by SDS-PAGE and to bind Ins 1,4,5-P3 with a Kd of 100 nM at pH 8.3 . In contrast to studies with cerebellar membrane fractions, where Ca2+ was shown to inhibit Ins 1,4,5-P3 binding with a half-maximal effect at 300 nM (160) , the binding of Ins 1,4,5-P3 to the purified receptor was unaffected by Ca21 (163) . The Ca2+ sensitivity is apparently conferred by a separate protein present in solubilized brain membranes having an estimated Mr of 300,000 by gel filtration (164) . The effect of Ca21 in cerebellar membranes is to decrease the affinity of Ins 1,4,5-P3 binding to the receptor (165) . An increase of extravesicular Ca2' in the range from 1 to 10 jM has been shown to inhibit Ins 1,4,5-P3-induced Ca2+ release in permeabilized neuronal cells and microsomes (137, 166) . In studies with cerebellar microsomes, the concentration of Ca2+ required for inhibition was lower at suboptimal Ins 1,4,5-P3 concentrations (165 (1, 2, 16) . Evidence with hepatocytes has indicated that the onset of net Ca2" efflux is delayed by 5 to 10 sec after agonist addition, indicating that there is an initial inhibition of the plasma membrane Ca2+ efflux pump (167) . The mechanism of this effect has not been ascertained, but it may relate to the altered inositol lipid environment of the Ca2+-ATPase (168) or to a direct inhibitory effect of Ins 1,4,5-P3 (169) . Subsequently, however, this inhibition is overcome so that Ca2+ efflux is stimulated above the resting rate. This can be attributed partly to the Ins 1,4,5-P3-induced increase of cytosolic free Ca2 , which stimulates the calmodulin-dependent plasma membrane Ca2+-ATPase and the electrogenic Na+/Ca2+ exchanger. The latter system is present in the plasma membrane of many cells (170 Ca2' and an increase of unidirectional 45Ca2`influx (1, 2) . The temporal relationship between intracellular Ca2+ release and stimulated influx appears cell specific, since rapid kinetic measurements show that the onset of stimulated Ca2`influx occurs at least as rapidly as intracellular Ca2" release in parotid cells (130) and platelets (131) . In A10 smooth muscle (132) and GH3 pituitary (176) (178) , the response to Ca2+ mobilizing agonists may be associated with a hyperpolarization because of a secondary Ca2+ activation of K+ and Cl-channels. Alternatively, agonistinduced Ca2" entry is considered to be regulated by a process usually referred to as a receptor-operated Ca2`channel. This entry of Ca21 is only inhibited by agents that block voltage-sensitive Ca2`channels when they are added at very high concentrations (120). In fact, several mechanisms may mediate activation of Ca2`channels by receptor occupation. One mechanism is by direct ligand activation, which appears to occur with the ATP-activated high conductance cation channel in smooth muscle (179) . Another mechanism is by receptor-activated G-proteins, which have been demonstrated to regulate several types of K+ and Ca2`channels in a variety of cells (reviewed in 180). Evidence consistent with a role for a G-protein in activating receptor operated Ca2+ channels is suggested from the observations that pretreatment with pertussis toxin inhibited Ca2+ influx, which was induced by vasopressin in hepatocytes (181) and by angiotensin II in adrenal glomerulosa cells (182), but did not affect intracellular Ca2+ mobilization. A nonselective cation channel activated by a rise of cytosolic free Ca2+ has been reported (183, 184) , but in most cells the onset of Ca21 influx does not lag behind intracellular Ca2`mobilization. Stimulated Ca2+ influx persists after the initial Ca2" transient, and it is dependent on receptor occupancy, rather than on the cytosolic free Ca2' concentration (120,121,123,185 ).
An attractive possibility that has generated considerable attention is that Ins 1,4,5-P3, itself, or one of its metabolic products may be responsible for agoniststimulated Ca2" influx. Ins 1,4,5-P3-induced Ca2" release has been demonstrated in Na+-loaded plasma membrane vesicles from platelets (161) . Mitogenic stimulation of T lymphocytes has been shown to be associated with activation of a low conductance voltage-independent Ca2" channel in the cell-attached patch, which could be directly activated by Ins 1,4,5-P3 after excision of the patch (186) .
An involvement of Ins 1,3,4,5-P4 in mediating Ca2' influx was first suggested from microinjection experiments with sea urchin eggs (187) . Further studies showed that there was no effect of Ins 1,3,4,5-P4 on Ca2' influx, but at high concentrations, it induced release of intracellular Ca2' (188) . Experiments with Xenopus oocytes showed that an injection of Ins (191) . In contrast, studies with NIE-115 neuroblastoma cells showed that injection of Ins 1,3,4,-P3, but not Ins 1,3,4,5-P4, produced a membrane depolarization in 50% of the cells tested (192) .
In summary, it must be concluded that there is insufficient evidence to deduce the mechanism for (193, 194) , but their function has not yet been ascertained.
Oscillations in Cytosolic Free Ca2+
In contrast to the many studies with bulk cell suspensions where agonist-induced Ca2+ transients are typically biphasic, the development of methods for measuring changes of Ca2' in single cells has revealed that the response may be oscillatory. Measurements with the bioluminescent protein, aequorin, in single hepatocytes stimulated with agonist showed a series of periodic increases in cytosolic free Ca2' to above 600 nM, each returning to resting levels within 7 sec (195, 196) . The frequency of these oscillations was a function of phenylephrine concentration, with a period varying from 20 to 240 sec. Low concentrations of vasopressin and angiotensin II, which produce nonsaturating amounts of Ins 1,4,5-P3, caused similar oscillations, suggesting that the occurrence of Ca2+ oscillations is favored when tissue Ins 1,4,5-P3 concentrations are low. In contrast, Fura-2 loaded hepatocytes rarely exhibit Ca2' oscillations after addition of agonists (132) . However, in other cell types, oscillations of the cytosolic free Ca2' in a proportion of cells have been observed using Fura-2 as the Ca 2+ indicator. For example, BC3H-1 cells stimulated with phenylephrine exhibited a burst of Ca2`spikes that ceased after several minutes (197) , low concentrations of angiotensin II-elicited Ca2' oscillations in adrenal glomerulosa cells (133) and macrophages induced to spread onto a suitable substratum (frustrated phagocytosis) showed Ca2' oscillations (198) . In parotid acinar cells a damped series of oscillations could be evoked by carbachol, but in a concentration-independent manner (199) ; rat peritoneal mast cells stimulated with antigen responded variably with one, two, or more spikes of increased Ca2' (200) . Similarly, the addition of carbamylcholine to insulinoma HIT (T-15) cells loaded with Fura-2 produced a series of characteristic but damped Ca2`oscillations in each responding cell (201) . In general, measurements of Ca2`with The difference between the data obtained with aequorin and Fura-2 even in the same cell type, suggest that they may arise from the different properties of the Ca2' indicators. Since Fura-2 is a Ca2+ chelator, it is possible that it diminishes the peak rise of the Ca2' transients, which may be part of a negative feedback interaction responsible for generating the oscillations. On the other hand, the nonlinear relationship betwen aequorin bioluminescence and Ca2' concentration may amplify spatially localized oscillations of Ca2'. Thus, a series of transient, localized increases in Ca2' might be detected by aequorin as large, transient spikes, decaying rapidly as Ca2+ diffuses into the remainder of the cytosol, whereas Fura-2 might not detect such a response because of its lower sensitivity to local changes of the Ca2`concentration. However, sustained Ca21 oscillations have been observed in oocytes after fertilization using either Ca2+-selective microelectrodes (202) and Cl-channels. In HeLa cells, histamine stimulated a pattern of Ca2+-dependent channel activation, characterized by a series of bursts, which were separated by silent periods. These correlated with membrane potential oscillations and occurred in the absence of extracellular Ca21 (204) . Similarly, a1-adrenergic stimulation of voltage-clamped guinea pig hepatocytes induced oscillatory membrane conductance increases to K+ and Cl-, which were attributed to Ca2+-activated K+ and Cl-channels (205) . A close correlation between oscillatory Ca2"-activated K+ channel activity and intracellular Ca2' has been reported in hamster oocytes (202) , with similar responses being observed after injection of GTPyS (206) .
Mechanisms for the generation of Ca21 oscillations appear to fall into two categories: oscillations that occur secondary to spontaneous action potentials, as in some secretory cells (207) , and oscillations induced by Ca21-mobilizing hormones. The latter can be initiated in the absence of extracellular Ca2 , indicating that intracellular Ca2' release is the primary source of Ca2+, although extracellular Ca2' is required for their maintenance (197, 198, 204, 205) . A minimum oscillating system requires a feedback loop; for sustained oscillations, some delay step is required to generate the periodicity (208) . Theoretically, oscillations in the Ins 1,4,5-P3 concentration could be produced by a negative feedback effect on the receptor or the Gprotein coupled to activation of phospholipase C by protein kinase C. The delay step could be caused by a slow rate of activation of the G-protein or of protein kinase C by diacylglycerol. However, such a mechanism involving a periodically activated protein kinase C is difficult to reconcile with the decrease in the frequency of the Ca21 oscillations observed by addition of exogenous diacylglycerol or phorbol ester to hepatocytes (209 
